Patents
Patents for C07B 57 - Separation of optically-active organic compounds (3,737)
01/2003
01/23/2003US20030017942 Chiral catalysts for asymmetric acylation and related transformations
01/22/2003CN1099592C 分离剂 Separating agent
01/21/2003US6509478 Optically active poly (N-methylbenzylmaleimide), method for its production and its use
01/16/2003WO2003003804A2 Process for the production of optically active 3-phenylisoserine
01/16/2003WO2002076930A3 Substituted diarylureas as stimulators for fas-mediated apoptosis
01/16/2003WO2002029412A3 Selective binding materials
01/16/2003US20030013892 Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids
01/16/2003US20030010696 Separating agent for enantiomeric isomers
01/16/2003CA2450545A1 Process for the production of 3-phenylisoserine
01/15/2003EP1274685A1 A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
01/09/2003WO2001068637A3 Method for the preparation of tetrahydrobenzothiepines
01/03/2003WO2003000672A1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram
01/03/2003WO2003000636A1 Resolution process for (r)-(-)-2-hydroxy-2-(2-chlorophenyl) acetic acid
01/02/2003US20030004175 Viricides
01/02/2003EP1268584A1 Compositions and methods for selectively binding amines or amino acid enantiomers over their counter-enantiomers
01/02/2003EP1268369A1 Novel process for preparing (+)-cis-sertraline
12/2002
12/27/2002WO2002103349A1 Separatory agent for optical isomer
12/27/2002WO2001079174A8 A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
12/19/2002WO2002100804A2 Novel use of sulfamic acids as resolving agent.
12/19/2002WO2002059128A3 Process for preparing clopidogrel
12/18/2002CN1385409A Optical resolution method for recemic diphenol
12/18/2002CN1096450C Process for producing phenoxy propionic acid derivatives
12/17/2002US6495711 Process for preparing (-)-(1S, 4R) N-protected 4-amino-2-cyclopentene-1-carboxylate esters
12/12/2002WO2002098923A1 New derivatives of hyaluronan
12/11/2002EP1264815A2 Separating agent for enantiomeric isomers
12/11/2002EP1264814A1 Resolving agents based on amines
12/05/2002WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002US20020183281 For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, pain
12/03/2002US6489513 Reacting aromatic bromine compound with diphenylphosphinic chloride in a mixture of tetrahydrofuran and aromatic hydrocarbon to give a diphenylphosphine oxide, isolating, metalating; reacting with iodine, reacting with copper
11/2002
11/28/2002WO2002094801A1 Method for producing biperiden i
11/27/2002EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/26/2002US6485650 Liquid membrane separation of enantiomers
11/21/2002WO2002092562A2 Enantioselective reactions using two-component chiral phase transfer catalysts in multiphasic systems
11/20/2002EP1257527A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
11/20/2002EP1257360A1 Chiral ferrocene phosphines and their use in asymmetric catalytic reactions
11/19/2002CA2072162C Diastereomer salt of optically active quinolinemevalonic acid
11/07/2002WO2002088149A2 A process for manufacture of fosinopril sodium
11/07/2002WO2002088049A1 Separatory agent for optical isomer
11/07/2002WO2002088048A1 Separatory agent comprising polysaccharide derivative having polycyclic structure
11/07/2002US20020165393 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
11/07/2002CA2411876A1 A process for manufacture of fosinopril sodium
11/06/2002EP1254092A1 Resolution of dl-racemic mixtures
11/06/2002CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
10/2002
10/31/2002WO2002085836A1 Binaphtol derivative and process for producing the same
10/29/2002CA2071979C Process for the preparation of cis-beta-phenylglycidic-(2r,3r)acid
10/24/2002WO2001098265B1 Process for isolating enantiomers of racemic cetamine
10/23/2002EP1250315A1 Functional monomers for molecular recognition and catalysis
10/23/2002EP1250299A2 Chiral ionic liquids
10/22/2002US6469007 P-substituted-n-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-n-pyridin-2-yl-benzamide,
10/17/2002US20020151744 Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids
10/17/2002US20020151596 Novel process to prepare 2-aminoindan derivatives
10/15/2002US6465684 Process for the separation of a mixture of enantiomers
10/15/2002US6465664 Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems
10/09/2002EP1246789A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors
10/08/2002US6462229 It has been found that (.+-.)-.alpha.-difluoromethylornithine can be cleaved using the commercially obtainable (-)-o,o'-di-p-toluoyl-l-tartaric acid
10/08/2002US6462200 Diphosphines
10/03/2002WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002WO1998008787A3 Resolution of racemic mixtures using polymers containing chiral units
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
09/2002
09/25/2002CN1371356A Enatiomerically-enriched compounds having photocleavable bond(s) and methods related thereto
09/19/2002WO2002072514A1 Methods and compositions for enantioselective oxidation reactions
09/19/2002US20020133031 Catalytic asymmetric epoxidation
09/19/2002US20020133017 Chromatographic separation of enantiomers of lactones
09/18/2002CN1370145A Novel process
09/17/2002US6451854 α-amino acid phenyl ester derivatives
09/12/2002WO2002070123A1 Separating agent for optical isomer
09/11/2002EP1237847A1 Method for the stereoselective synthesis of cyclic amino acids
09/11/2002EP1237838A1 New process
09/11/2002EP1237831A1 Screening for optimal yield in the crystallisation of multicomponent systems
09/10/2002US6448414 Hydrolytic kinetic resolution of cyclic substrates
09/10/2002US6448402 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol
09/06/2002WO2002068404A1 Method for producing optically active dihydropyrones
09/05/2002DE10108470A1 Verfahren zur Herstellung optisch aktiver Dihydropyrone A process for preparing optically active dihydropyrones
09/03/2002US6444854 Process for the production of enantiomerically pure or optically enriched sertraline-tetralone using continuous chromatography
08/2002
08/29/2002WO2002044177A3 Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
08/28/2002EP1233828A2 Chiral catalysts for asymmetric acylation and related transformations
08/28/2002EP1124798A4 Synthesis of methylthiophenyl hydroxyketones
08/28/2002EP1019363B1 Process for the preparation of an inorganic salt of an optically active phenylglycine derivative
08/27/2002US6441048 Methods of treating affective disorders using derivatives of (-)-venlafaxine
08/21/2002EP1232279A2 Method for producing optically active amines
08/21/2002EP1232155A1 Protease inhibitors
08/21/2002EP1231922A1 Protease inhibitors
08/20/2002US6437167 Chiral stationary phases for enantiomers separation and their preparation
08/20/2002US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders
08/15/2002WO2001098265A3 Process for isolating enantiomers of racemic cetamine
08/15/2002US20020111512 Dynamic resolution of isomers and resolved isomers
08/14/2002EP1230260A1 Hcv ns3 protease inhibitors
08/14/2002EP1229915A1 Protease inhibitors
08/13/2002CA2189000C Process and diastereomeric salts useful for the optical resolution of racemic .alpha.-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol and derivative compounds
08/13/2002CA2111447C Hypoglycemic thiazolidinediones and intermediates
08/08/2002WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
08/08/2002US20020107254 P-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide,
08/07/2002EP1227883A1 Catalyst for asymmetric transfer hydrogenation
08/06/2002CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides
08/01/2002WO2002059128A2 Process for preparing clopidogrel
08/01/2002WO2002030918A3 PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID
07/2002
07/25/2002WO2002020529A8 METHOD FOR OBTAINING 4-(N-ALKYLAMINE)-5, 6-DIHYDRO-4H-THIENO-(2,3-b)-THIOPYRAN-2-SULFAMIDE-7, 7-DIOXIDES AND INTERMEDIATE PRODUCTS
07/25/2002CA2435132A1 Compositions comprising higher diamondoids and processes for their separation
07/24/2002EP1224167A1 Resolution of intermediates in the synthesis of substantially pure bicalutamide
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 38